- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01707810
Prospective Trial Comparing Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver (LTx-outflow)
Prospective Randomized Trial Comparing the Clinical Efficiency of Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Thirty-two patients recruited among liver transplant recipients submitted to surgery at the Liver Unit at the Hospital das Clínicas of the University of São Paulo Medical School between 8 th October, 1999 and 30 rd September, 2000 were studied. The patients were assigned by randomization to two groups: transplant performed using the conventional or the piggyback method. These patients are part of a larger clinical trial where pulmonary alterations are compared between patients operated using the conventional method with venovenous bypass and the piggyback method.(10) Inclusion criteria admitted of both genders, aged 18 years or older, submitted to a first elective LTx, with no clinical or technical reasons justifying a preferential option by conventional or piggyback method. For this reason, we excluded patients submitted to living donor LTx, in whom IVC is routinely preserved and those with familial amyloidotic polyneuropathy, whom, in our routine, are routinely submitted to conventional LTx.
The randomization process was performed by a team of nurses not involved with the intraoperative care of the patients. This was obtained by "coin-tossing". In each case, randomization was paired according to the Child-Pugh's Score, calculated immediately before surgery. Stratification was performed by blocking randomization in each subset of patient (scores A, B, or C), with blocks of size 2 with a one-to-one allocation ratio. Thus, while the first patient of each Child-Pugh score was effectively randomized, the second was automatically allocated to the opposite surgical method, completing a pair. However, the investigators had no influence on the second recipient selection due to the characteristics of the organ allocation system in Brazil, former MELD scale criteria was introduced. In that time, the graft distribution was according to four distinct blood groups (A,B,AB,O) generated a greater obstacle to predicting who would be the next patient as related to what would be obtained if blocks of 4 size have been used.
Surgeries of donor and of recipient were performed with small adaptations in the usual technique in order to evaluate the pressure gradient between the hepatic vein and the right atrium in the two groups. In the conventional method IVC was clamped during the anhepatic phase and venous return was maintained by a portal femoral axillary venovenous bypass with a centrifugal pump. In these cases, IVC reconstruction was performed by end-to-end anastomosis above and below the liver. In the piggyback method IVC was not clamped in any case. Implantation method of the grafted IVC in recipient IVC was not standardized, being defined by the responsible surgeon during the procedure. In the two groups, all patients were submitted to simultaneous arterial and portal revascularization, according to the routine of the service.
Free hepatic vein pressure (FHVP) was measured using an 8F polyethylene catheter with a multiperforated distal end, which was positioned in the graft's right hepatic vein during ex situ preparation on the back table. The proximal end of this catheter was exteriorized in the infrahepatic portion of IVC. In the conventional group, exteriorization was performed through the anastomosis suture. In the piggyback group, IVC was ligated around the catheter. Central venous pressure (CVP) was obtained using a Swan-Ganz catheter (routine procedure). Measurement of hepatic vein and right atrium pressure was made once, after concluding biliary anastomosis.
All measurements were obtained with the same transducer, determining as zero reference level the median axillary line. Pressure measurement was performed in apnea in order to avoid that the patient's respiratory incursions would determine oscillations in the pressure curve. When oscillations persisted in spite of this maneuver, the arithmetic mean of the observed maximum and minimum values was recorded. "hepatic venous block" was considered when a pressure gradient higher than 3 mm Hg was present.(4) Serum creatinine (Cr) was determined in the preoperatory period (immediately before surgery), on postoperative days (PO) 1 to 7 and on 14, 21 and 28. Occurrence of acute renal failure (ARF) was defined as postoperative creatinine peak > or = 2.0. (8) For each case, the area under the curve (AUC) Cr vs. time, calculated by the trapezoidal method (11) and divided by the postoperative observation time (28 days), was used as a postoperative overall creatinine parameter. Each group, conventional and piggyback, are also analyzed according to the RIFLE which classifies ARF in three grades of increasing severity: risk (class R), injury (class I) and failure (class F) - and two outcome classes - loss and end-stage kidney disease. RIFLE classification provides these grades based on changes in either Cr or urine output from the baseline condition. The RIFLE criteria is an important tool to help the international community compare data on ARF and was validated elsewhere (12, 13), being modified in 2005 as RIFLE-AKIN (14). For statistical analysis, in this study, the Class R are unified with the group of patients without renal injuries (considered as nule alterations), and the patients with class I and F were unified. The outcome classes are late consequences of the LTx and were not studied in the present clinical trial.
Postoperative massive ascites was considered as abdominal fluid accumulation with a volume over 500 ml/day for more than 30 days (6) evaluated through body weight, abdominal drain output or paracentesis.
The patients were followed up until 30 rd June, 2006, recording the date of death of those who died.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria admitted of both genders, aged 18 years or older, submitted to a first elective LTx, with no clinical or technical reasons justifying a preferential option by conventional or piggyback method
Exclusion Criteria:
- patients submitted to living donor LTx, in whom IVC is routinely preserved and those with familial amyloidotic polyneuropathy, whom, in our routine, are routinely submitted to conventional LTx.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Conventional method
In the conventional method IVC was clamped during the anhepatic phase and venous return was maintained by a portal femoral axillary venovenous bypass with a centrifugal pump.
In these cases, IVC reconstruction was performed by end-to-end anastomosis above and below the liver.
|
|
|
Experimental: Piggyback method
In the piggyback method IVC was not clamped in any case.
Implantation method of the grafted IVC in recipient IVC was not standardized, being defined by the responsible surgeon during the procedure.
In the two groups, all patients were submitted to simultaneous arterial and portal revascularization, according to the routine of the service.
|
In the piggyback method IVC was not clamped in any case.
Implantation method of the grafted IVC in recipient IVC was not standardized, being defined by the responsible surgeon during the procedure.
In the two groups, all patients were submitted to simultaneous arterial and portal revascularization, according to the routine of the service.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hepatic vein and right atrium pressure measurements (observed FHPV-CVP gradient values)
Time Frame: intraoperatory
|
Free hepatic vein pressure (FHVP) was measured using an 8F polyethylene catheter with a multiperforated distal end, which was positioned in the graft's right hepatic vein during ex situ preparation on the back table.
The proximal end of this catheter was exteriorized in the infrahepatic portion of IVC.
In the conventional group, exteriorization was performed through the anastomosis suture.
In the piggyback group, IVC was ligated around the catheter.
Central venous pressure (CVP) was obtained using a Swan-Ganz catheter (routine procedure).
Measurement of hepatic vein and right atrium pressure was made once, after concluding biliary anastomosis.
|
intraoperatory
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum Creatinine
Time Frame: postoperative days (PO) 1 to 7 and on 14, 21 and 28
|
Serum creatinine (Cr) was determined in the preoperatory period (immediately before surgery), on postoperative days (PO) 1 to 7 and on 14, 21 and 28.
Occurrence of acute renal failure (ARF) was defined as postoperative creatinine peak > or = 2.0
|
postoperative days (PO) 1 to 7 and on 14, 21 and 28
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Paulo CB Massarollo, PhD, Faculdade de Medicina da Universidade de Sao Paulo
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LIVER TRANSPLANT OUTFLOW
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End-stage Liver Disease
-
Bridge to Life Ltd.Enrolling by invitationLiver Failure | End Stage Liver DIseaseUnited States
-
Vanderbilt University Medical CenterSuspendedEnd Stage Liver DIseaseUnited States
-
Virginia Commonwealth UniversityCompletedEnd Stage Liver DIseaseUnited States
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonCompletedEnd-stage Liver DiseaseUnited Kingdom
-
Proteonomix, Inc.University of Medicine and Dentistry of New Jersey; NumodaUnknownEnd Stage Liver DIseaseUnited States
-
University of ZurichUniversity Ghent; University Hospital of Sao Paulo, BrazilCompleted
-
RenJi HospitalNot yet recruitingEnd Stage Liver DIsease
-
Huashan HospitalRecruiting
-
Beijing Chao Yang HospitalUnknownLiver Transplantation | End Stage Liver DIseaseChina
-
Mayo ClinicRecruiting
Clinical Trials on conventional method
-
Dr. Behcet Uz Children's HospitalRecruitingAcute Respiratory Distress Syndrome | Acute Respiratory Failure | Pediatric Acute Respiratory Distress Syndrome (PARDS)Turkey
-
Indonesia UniversityCompletedPremature | Feeding; Difficult, NewbornIndonesia
-
University of MalayaCompleted
-
Medical University of GrazCompletedIntubation; Difficult or Failed | Preterm Infant | Term InfantAustria
-
Universidad de la SabanaUniversidad Ramón LlullUnknownLow Back Pain, Mechanical
-
University Hospital, MontpellierCompletedArteriovenous Fistula CannulationFrance
-
Malmö UniversityOrtodontilund ABRecruiting
-
Riphah International UniversityNot yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulRecruitingRespiratory Complications | Diaphragmatic Excursion | Pulmonary SpirometryBrazil
-
TC Erciyes UniversityCompletedCognitive Dysfunction, PostoperativeTurkey (Türkiye)